Led by Pfizer, co-led by Merck KGaA (Darmstadt, Germany) and coordinated by Universidad Politécnica de Madrid (UPM) the five-year project – “BEhavioral and Adherence Model for improving quality, health outcomes and cost-effectiveness of healthcaRe (BEAMER)” – brings together 27 European partners from academia, civil society and industry to jointly address adherence to treatment.